Webull Launches in the United Kingdom

LONDON, July 12, 2023 (GLOBE NEWSWIRE) — Webull Corporation (“Webull”), the owner of the popular Webull trading platform, today announced the launch of its retail brokerage services in the UK. Through licensed financial services trading firm Webull Securities (UK) Ltd. (“Webull UK”), a subsidiary of Webull, residents of the UK can now trade U.S.-listed equities […]

Continue Reading

Rediscovering History: Exploring the Fascinating the Ancient Tea-Horse Road in Yunnan

Rediscover The Ancient Tea-Horse Road KUNMING, China, July 12, 2023 (GLOBE NEWSWIRE) — Yunnan Innyo Co., Ltd. is excited to collaborate with @visityunnan and share a series of videos of the Ancient Tea-Horse Road in Yunnan, China. The videos feature charming villages, famous tea mountains, delicious local cuisine, and comfortable accommodations, making Yunnan’s Ancient Tea-Horse […]

Continue Reading

LeddarTech and Ficosa Intensify Collaboration for Innovative Smart Parking Assistant

QUEBEC CITY, July 12, 2023 (GLOBE NEWSWIRE) — LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, is thrilled to announce the successful integration of LeddarTech’s advanced LeddarVision™ software with Ficosa’s cutting-edge surround-view camera system, along with other sensors such as radars, IMU and […]

Continue Reading

Plug Power to Supply Two 5 MW PEM Electrolyzers for Australian Green Hydrogen Projects

Plug electrolyzers will contribute to decarbonization of road transportation and natural gas sectors LATHAM, N.Y., July 11, 2023 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has been selected to supply two 5-megawatt (MW) proton exchange membrane (PEM) electrolyzer systems for green hydrogen […]

Continue Reading

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab

SHANGHAI, China, July 11, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the supplemental new drug application for toripalimab, the company’s anti-PD-1 monoclonal antibody, in combination with axitinib for the first-line […]

Continue Reading